Brief: Kilitch Drugs India Plans To Focus On African Markets

Kilitch Drugs (India)

07/08/2018 14:57

Aug 7 (Reuters) - Kilitch Drugs India Ltd  KIDI.NS :
    * PLANS TO FOCUS ON AFRICAN MARKETS WITH CEPHALOSPORIN
INJECTABLE
PLANT NEAR ADIS ABABA IN ETHIOPIA
    * SAYS UNIT WILL HAVE A CAPACITY OF 20 MILLION VIALS AND
COMMENCE
OPERATIONS IN FY 2019 - 2020
    * SAYS BESIDES VIALS, PLANT WILL ALSO PRODUCE TABLETS,
CAPSULES,
DRY SYRUP
    * BY 2020, KDIL PLANS TO REGISTER MORE THAN 500 PRODUCTS IN
AFRICAN MARKET
    * PRESENCE IN AFRICA WOULD MEAN "POTENTIAL DOUBLING OF
REVENUES
AND SIGNIFICANT IMPROVEMENT IN MARGINS"

Source text: http://bit.ly/2AKhAUp
Further company coverage:  KIDI.NS 

 ((Reuters.Briefs@thomsonreuters.com;))